Literature DB >> 8394686

Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1.

D Tewari1, J S Gibson, J D Slater, T O'Neill, D Hannant, G P Allen, H J Field.   

Abstract

EHV-1 was inoculated into specific pathogen-free (SPF) foals in order to study uncomplicated primary responses. Infection resulted in a strong serological response recognizing EHV-1-specific antigens; this contrasts with a previous publication where a weak response was recorded in SPF animals. Antibodies to EHV-1 were readily detected by four techniques (virus neutralization, complement fixation, Western blots and immune precipitation), yet there was comparatively little cross-reaction to EHV-4 target antigen. Re-inoculation with the same virus strain stimulated antibodies to EHV-1 but no additional antigens were recognized and antibodies cross-reacting with EHV-4 antigens were not enhanced. Having characterized the uncomplicated primary response to EHV-1 in SPF foals, further animals were exposed to either EHV-4 or a thymidine kinase-deficient mutant of EHV-1 prior to challenge with w/t EHV-1 to investigate how these infections might modulate the immune responses to EHV-1 or 4. Primary inoculation with EHV-4 or with a thymidine kinase-deficient mutant of EHV-1 produced productive infections as evidenced by virus shedding and pyrexia. In both these cases, however, in contrast to that with w/t EHV-1, the serological response was very weak. Re-infection of foals primed with either EHV-4 or TK-deficient EHV-1 with w/t EHV-1 resulted in a strong response to EHV-1 antigens detected by all four methods. In addition, in the foals given a primary inoculation with EHV-4, superinfection with EHV-1 resulted in a strong cross-reactive response to EHV-4 target antigens. The relevance of these observations to the interpretation of previously reported serological responses to EHVs in SPF and naturally reared animals is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394686     DOI: 10.1007/bf01309846

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

1.  The raising of equine colostrum-deprived foals; maintenance and assessment of specific pathogen (EHV-1/4) free status.

Authors:  Y C Chong; W P Duffus; H J Field; D A Gray; A R Awan; M A O'Brien; D P Lunn
Journal:  Equine Vet J       Date:  1991-03       Impact factor: 2.888

2.  Clinical signs and humoral immune response in horses following equine herpesvirus type-1 infection and their susceptibility to equine herpesvirus type-4 challenge.

Authors:  A Stokes; A H Corteyn; P K Murray
Journal:  Res Vet Sci       Date:  1991-09       Impact factor: 2.534

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.

Authors:  G P Allen; J T Bryans
Journal:  Prog Vet Microbiol Immunol       Date:  1986

5.  Latency of equine herpesvirus 4 (equine rhinopneumonitis virus)

Authors:  G F Browning; D M Bulach; N Ficorilli; E A Roy; B H Thorp; M J Studdert
Journal:  Vet Rec       Date:  1988-11-12       Impact factor: 2.695

6.  The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection.

Authors:  A R Awan; Y C Chong; H J Field
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

7.  Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.

Authors:  F Bürki; W Rossmanith; N Nowotny; C Pallan; K Möstl; H Lussy
Journal:  Vet Q       Date:  1990-04       Impact factor: 3.320

8.  The acyclic nucleoside analogue penciclovir is a potent inhibitor of equine herpesvirus type 1 (EHV-1) in tissue culture and in a murine model.

Authors:  R de la Fuente; A R Awan; H J Field
Journal:  Antiviral Res       Date:  1992-05       Impact factor: 5.970

9.  Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.

Authors:  S Kit; M Kit; E C Pirtle
Journal:  Am J Vet Res       Date:  1985-06       Impact factor: 1.156

10.  Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).

Authors:  D R Fitzpatrick; M J Studdert
Journal:  Am J Vet Res       Date:  1984-10       Impact factor: 1.156

View more
  3 in total

1.  Pathogenesis and clinical signs of equine herpesvirus-1 in experimentally infected ponies in vivo.

Authors:  G A Sutton; L Viel; P S Carman; B L Boag
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

2.  Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.

Authors:  D Tewari; S V Nair; M C De Ungria; G L Lawrence; M Hayden; D N Love; H J Field; J M Whalley
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Molecular Detection of Equine Herpesvirus Types 1 and 4 Infection in Healthy Horses in Isfahan Central and Shahrekord Southwest Regions, Iran.

Authors:  Taghi Taktaz Hafshejani; Shahin Nekoei; Behnam Vazirian; Abbas Doosti; Faham Khamesipour; Madubuike Umunna Anyanwu
Journal:  Biomed Res Int       Date:  2015-09-01       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.